Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS.

At 6 months, the proportion of participants achieving UPCR ≤0.5 g/g was numerically greater in the voclosporin arm compared to the IVC arm, although the difference did not reach statistical significance; the proportion of participants achieving UPCR ≤0.5 g/g was significantly greater in the voclosporin arm compared to the MMF arm (p<0.005).

also in 17,681 other papers